Brief: Repare Therapeutics Estimates Cash, Cash Equivalents As Of Dec 31, 2021 About $341.7 Mln
10/01/2022 12:47
Jan 10 (Reuters) - Repare Therapeutics Inc RPTX.O :
* REPARE THERAPEUTICS-PRELIMINARILY ESTIMATES CASH, CASH
EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES AS OF DEC
31, 2021 WAS ABOUT $341.7 MILLION
Source text for Eikon: ID:
Further company coverage: RPTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Repare Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Repare Therapeutics Announces Acquisition Of Polθ ATPase Inhibitor, RP-3467, By Gilead Sciences For Up To $30 Million In Total Consideration
Brief: Repare Signs Support Agreements With Key Shareholders For Xenotherapeutics Deal
Repare Therapeutics Q2 net loss narrows to $16.7 mln